Analogous tamoxifen and estrogen effects on transforming growth factor-betas 1 and 2 in the rat uterus

This publication has 20 references indexed in Scilit:

• Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
  The Lancet, 1994
• Endometrial Cancer in Tamoxifen-Treated Breast Cancer Patients: Findings From the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14 *
  JNCI Journal of the National Cancer Institute, 1994
• Tamoxifen: disease prevention or disease substitution?
  The Lancet, 1992
• Hysteroscopic follow-up during Tamoxifen treatment
  European Journal of Obstetrics & Gynecology and Reproductive Biology, 1990
• ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERS
  The Lancet, 1989
• Expression of Transforming Growth Factor α and its Messenger Ribonucleic Acid in Human Breast Cancer: Its Regulation by Estrogen and its Possible Functional Significance
  Molecular Endocrinology, 1988
• Estrogen Induces Insulin—Like Growth Factor—I Expression in the Rat Uterus
  Molecular Endocrinology, 1987
• Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells
  Cell, 1987
• Autocrine and paracrine growth regulation of human breast cancer
  Breast Cancer Research and Treatment, 1986
• Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens
  New England Journal of Medicine, 1975